Table 4.
Diagnostic Group | Wilcoxon Rank Test | |||
---|---|---|---|---|
PAE (n = 19) | Unexposed Controls (n = 40) | |||
Externalizing Problems composite score | Median score (IQR) 1 | 68 (10) | 50 (9) | W = 604, p < 0.001 ** |
At risk (60–69) | 9 (47%) | 4 (10%) | ||
Clinically significant ≥ 70 | 5 (26%) | 2 (5%) | ||
Total | 14 (73%) | 6 (15%) | ||
Aggression subscale | Median score (IQR) | 60 (11) | 50 (8) | W = 604, p < 0.001 ** |
At risk (60–69) | 8 (42%) | 2 (5%) | ||
Clinically significant ≥ 70 | 2 (11%) | 2 (5%) | ||
Total | 10 (53%) | 4 (10%) | ||
Conduct subscale | Median score (IQR) | 60 (16) | 51 (14) | W = 575, p = 0.002 * |
At risk (60–69) | 5 (26%) | 5 (12.5%) | ||
Clinically significant ≥ 70 | 5 (26%) | 3 (7.5%) | ||
Total | 10 (52%) | 8 (20%) | ||
Hyperactivity subscale | Median score (IQR) | 69 (14) | 50 (10) | W = 626, p < 0.001 ** |
At risk (60–69) | 8 (42%) | 5 (12.5%) | ||
Clinically significant ≥ 70 | 6 (32%) | 2 (5%) | ||
Total | 14 (74%) | 8 (17.5%) | ||
Internalizing Problems composite score | Median score (IQR) | 50 (19) | 50 (15) | W = 423, p = 0.490 |
At risk (60–69) | 2 (11%) | 3 (7.5%) | ||
Clinically significant ≥ 70 | 4 (21%) | 4 (10%) | ||
Total | 6 (32%) | 7 (17.5%) | ||
Anxiety subscale | Median score (IQR) | 49 (23) | 49 (16) | W = 372, p = 0.900 |
At risk (60–69) | 5 (26%) | 3 (8%) | ||
Clinically significant ≥ 70 | 2 (11%) | 5 (13%) | ||
Total | 7 (37%) | 8 (20%) | ||
Depression subscale | Median score (IQR) | 58 (15) | 51 (11) | W = 477, p = 0.119 |
At risk (60–69) | 4 (21%) | 3 (8%) | ||
Clinically significant ≥ 70 | 4 (21%) | 4 (10%) | ||
Total | 8 (42%) | 7 (18%) | ||
Somatization subscale | Median score (IQR) | 50 (27) | 48 (14) | W = 428, p = 0.445 |
At risk (60–69) | 1 (5%) | 6 (15%) | ||
Clinically significant ≥ 70 | 5 (26%) | 1 (3%) | ||
Total | 6 (32%) | 7 (18%) |
1 IQR = interquartile range, * p < 0.05, ** p < 0.001.